Why Dr. Bronner’s is Donating $10 Million to MAPS for MDMA Research
September 9, 2020
David Bronner, the Cosmic Engagement Officer (CEO) of the soap company Dr. Bronner’s, tells Lucid News that the company has committed $10 million over 10 years to the Multidisciplinary Association for Psychedelic Studies for advancing psychedelic medical research. He also talks about the importance of supporting MAPS’ nonprofit approach to MDMA research, Dr. Bronner’s “Heal Soul” campaign which supports public education and advocacy efforts around psychedelics, and more.